Sci. STKE, 8 May 2007
Medicine Tau Reduction and Cognitive Decline
Stella M. Hurtley
Science, AAAS, Cambridge CB2 1LQ, UK
The brain pathology in Alzheimers disease involves both neurofibrillary tangles rich in the protein tau and plaques containing amyloid- peptide (A), but the relative contribution of each to cognitive impairment is unclear. Roberson et al. found that cognitive and neuronal deficits in two transgenic mouse models of Alzheimers disease are prevented when endogenous tau production is eliminated or reduced by 50%. The effect of tau reduction was robust, despite the absence of tau mutations, hyperphosphorylation, overexpression, or aggregation into neurofibrillary tangles in these models. Tau reduction did not block plaque-associated neuritic dystrophy, indicating that neuritic dystrophy can be dissociated both from tau and from A-induced cognitive impairments.
E. D. Roberson, K. Scearce-Levie, J. J. Palop, F. Yan, I. H. Cheng, T. Wu, H. Gerstein, G.-Q. Yu, L. Mucke, Reducing endogenous tau ameliorates amyloid -induced deficits in an Alzheimers disease mouse model. Science 316, 750-754 (2007). [Abstract] [Full Text]
Citation: S. M. Hurtley, Tau Reduction and Cognitive Decline. Sci. STKE 2007, tw163 (2007).
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882